|
英文药名: Omepral Injection（Omeprazole Sodium Hydrate）
中文药名: 奥美拉唑钠冻干粉注射剂
适应病症：胃溃疡、十二指肠溃疡
生产厂家: 阿斯利康
オメプラール注用20
类别名称
质子泵抑制剂
欧文商標名
Omepral Injection 20
一般名：オメプラゾールナトリウム水和物（Omeprazole Sodium Hydrate）（JAN）
化学名：(RS)-Monosodium 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl sulfinyl]benzimidazolate monohydrate
構造式：
分子式：C17H18N3NaO3S・H2O
分子量：385.42
性状：
奥美拉唑水合物钠是一种白色结晶粉末。非常易溶于水，易溶于乙醇（95），在乙腈中微溶。水溶液（1→10）示出了没有旋光性。
适应病症：
1. 口服给药不可能下列疾病：
胃溃疡伴有出血，十二指肠球部溃疡，急性应激性溃疡和急性胃黏膜病变。
2. 口服不可能卓 - 艾综合征。
用法用量
成人一次20毫克奥美拉唑，每天与天站生理盐水或一天站5％葡萄糖注射液，或一天站生理盐水或一天站5％的混合静脉滴注的两倍它溶解在葡萄糖注射液20ml静脉注射慢慢一天两次。
包装规格
洛赛克™注射20：[小瓶] 10瓶（20毫克×10瓶）
制造厂商
阿斯利康有限公司
注：以上中文资料仅供参考，使用以原处方资料为准：http://www.info.pmda.go.jp/go/pack/2329403D1025_1_14/
Omepral
Japan's first proton pump inhibitor injection drug"Losec ™ Note for 20"
AstraZeneca
AstraZeneca has recently proton pump inhibitor "Losec ™ Injection 20": The newly released from (generic name omeprazole sodium) on June 1.
The agent in the injectable formulations of omeprazole, are gastric ulcer with impossible bleeding of oral administration, duodenal ulcer, acute stress ulcer and acute gastric mucosal lesion, as well as oral administration impossible Zollinger-Ellison syndrome and indications.
Omeprazole is a benzimidazole derivatives Asutorahesura, Inc. (now AstraZeneca) were synthesized, to inhibit the proton pump responsible for the final process of the gastric acid secretion.
The main characteristics,
<1> sustained and excellent gastric pH control,
<2> of hemostasis postoperative excellent rebleeding preventive effect.
In there was a side effect 11 cases out of 850 cases reported in up to approval (1.3%), the main thing is, nausea 3 cases (0.4%), other gastrointestinal symptoms such as diarrhea 3 cases (0.4%), vascular pain 2 cases (0.2%).
Omeprazole, more than 70 countries around the world as an injection, also, as the oral agent has been approved in more than 100 countries, the oral formulation has also been approved in 1991 in Japan.
|
